The UI Division of Infectious Diseases offers a broad range of research opportunities, with faculty members conducting research ranging from basic laboratory investigation, to translational research, to clinical trials, to clinical epidemiology. Our program provides a comprehensive exposure to virtually all aspects of clinical infectious disease, antimicrobial pharmacology, hospital and clinical epidemiology, diagnostic microbiology, and clinical immunology.
Dr. Stapleton studies the interactions between flaviviruses including hepatitis C virus and GB virus C with HIV. In addition, he and Drs. Meier and Winokur are active in clinical trials of vaccines and antiviral therapies with the opportunity for translational research.
Dr. Nauseef is the Director of the Inflammation Program, an interdisciplinary program that includes Drs. Weiss, Allen, Barker, and Sutterwala from the Division of Infectious Diseases and Dr. Jaap Ijdo from the Division of Rheumatology. Drs. Apicella, Banfi, Davis, Gioannini, McLendon, Moreland and Ramaswamy from other Departments at the University of Iowa are also members of the Inflammation Program. This group is active in studying various aspects of innate immunity and host-pathogen interactions with specific work related to MRSA, Helicobacter pylori, Francisella tularensis, and others, and they are located on the Oakdale Research Campus. http://www.medicine.uiowa.edu/CCOM/index.html
programs/inflammation/
Dr. Winokur is active in the area of antimicrobial resistance, especially resistance mechanisms and relationships between animal use of antimicrobials and resistance patterns. In addition, she leads the University of Iowa Vaccine Treatment Evaluation Unit, one of eight vaccine centers funded by the NIH for studying non-HIV vaccines.
Dr. Helms is the Director of the Office of Clinical Quality, Safety and Performance Improvement at UI Hospitals and Clinics.
Dr. Herwaldt focuses on areas of infection control and molecular epidemiology, with a particular focus on staphylococcal infections and on implementing national guidelines. She is co-director of the EIN program.
Dr. Kirchhoff is active in the area of trypanosomal infections, mainly Chagas disease.
Dr. Wilson studies the pathogenesis of Leishmania infections and is the director of the travel clinic. She has collaborative projects with two Adjunct Infectious Diseases Faculty in Brazil (Drs. Jeronimo and Carvalho), and is establishing an international training interactive program.
-
Dr. Diekema is the fellowship director of the Infectious Diseases Division, a co-director of the clinical microbiology laboratory, and focuses on areas on antibacterial and antifungal resistance.
Dr. Meier studies basic mechanisms of CMV pathogenesis and latency, and he is active in HIV clinical trials. He oversees the Iowa-Midwest AIDS Training and Education Center.
Dr. Miller directs the solid organ transplant infectious diseases program, and has clinical trials ongoing examining treatment of influenza and fungal infections in this patient population. She also serves as an Associate Program Director for the Internal Medicine Residency Program.
Dr. McCaffrey works on RNA interference and zinc-finger nuclease based therapeutics to treat hepatitis B virus infection. His laboratory also works on microRNA profiling in the liver.
Dr. Polgreen is currently the director of the Emerging Infection Network (EIN), an infectious diseases physicians' network sponsored by the CDC and IDSA to detect and gather information on various emerging and re-emerging infections. He is also active in the area of bioinformatics in relation to infectious disease, and prediction markets of influenza activity.
Dr. Streit's interests are in general clinical infectious diseases and in tropical medicine.
